Homozygous Smpd1 deficiency aggravates brain ischemia/ reperfusion injury by mechanisms involving polymorphonuclear neut
- PDF / 5,048,404 Bytes
- 14 Pages / 595.276 x 790.866 pts Page_size
- 59 Downloads / 182 Views
ORIGINAL CONTRIBUTION
Homozygous Smpd1 deficiency aggravates brain ischemia/ reperfusion injury by mechanisms involving polymorphonuclear neutrophils, whereas heterozygous Smpd1 deficiency protects against mild focal cerebral ischemia Nina Hagemann1 · Ayan Mohamud Yusuf1 · Carlotta Martiny1 · Xiaoni Zhang1 · Christoph Kleinschnitz1 · Matthias Gunzer2 · Richard Kolesnick3 · Erich Gulbins4 · Dirk M. Hermann1 Received: 7 July 2020 / Accepted: 15 September 2020 © The Author(s) 2020
Abstract By cleaving sphingomyelin into ceramide, which is an essential component of plasma membrane microdomains, acid sphingomyelinase (Asm) pivotally controls cell signaling. To define how the activation of the Asm/ceramide pathway, which occurs within seconds to minutes upon stress stimuli, influences brain ischemia/reperfusion (I/R) injury, we exposed male and female wildtype mice carrying both alleles of Asm’s gene sphingomyelinase phosphodiesterase-1 (Smpd1+/+), heterozygously Asm-deficient mice (Smpd1+/−) and homozygously Asm-deficient mice (Smpd1−/−) of different age (8, 12 or 16 weeks) to 30, 60 or 90 min intraluminal middle cerebral artery occlusion (MCAO). For studying the contribution of brain-invading polymorphonuclear neutrophils (PMN) to I/R injury, PMNs were depleted by delivery of a PMN-specific Ly6G antibody. In male and female mice exposed to 30 min, but not 60 or 90 min MCAO, homozygous Smpd1−/− consistently increased I/R injury, blood–brain barrier permeability and brain leukocyte and PMN infiltration, whereas heterozygous Smpd1+/− reduced I/R injury. Increased abundance of the intercellular leukocyte adhesion molecule ICAM-1 was noted on cerebral microvessels of Smpd1−/− mice. PMN depletion by anti-Ly6G delivery prevented the exacerbation of I/R injury in Smpd1−/− compared with wildtype mice and reduced brain leukocyte infiltrates. Our results show that Asm tempers leukocyte entry into the reperfused ischemic brain, thereby attenuating I/R injury. Keywords Ceramide-rich membrane microdomain · Focal cerebral ischemia · Middle cerebral artery occlusion · Inflammation · Intercellular adhesion molecule-1 · Leukocyte · Lipid raft · Sphingolipid
Introduction Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00395-020-00823-x) contains supplementary material, which is available to authorized users. * Dirk M. Hermann dirk.hermann@uk‑essen.de 1
Department of Neurology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany
2
Institute of Experimental Immunology and Imaging, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany
3
Memorial Sloan Kettering Cancer Center, New York City, NY, USA
4
Department of Molecular Biology, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany
Acid sphingomyelinase (Asm), which catalyzes the hydrolysis of sphingomyelin to ceramide, is a key enzyme in sphingolipid metabolism. Localized in lysosomes, Asm is translocated to the plasma membrane within a few s
Data Loading...
